Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Illumina is an applied genomics technology ... populations and population diversities using large sample sets. Genome sequencing gives you a high-resolution microscope. Reducing the price of ...

CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single ... X systems. Sequencing instruments revenue totaled $155 ...

Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results , but sales were flat year on year at $1.1 billion. On the ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

The Genomics Core now has an Illumina NextSeq500 Next Generation Sequencing ... the capability of performing standard fluorescent and Next-Generation Sequencing (NGS), high and low throughput custom ...

which addresses current issues in sample preparation and provides a simplified procedure amenable to high-throughput workflows. Most second-generation sequencers use technologies for sequencing ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

ILMN reported fourth-quarter 2024 adjusted earnings per share (EPS) of 86 cents, which missed the Zacks Consensus Estimate of ...

CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted significant ...